Objective: Diabetes mellitus has been implicated as a risk factor for tardi
ve dyskinesia. The authors examined the association between abnormal moveme
nts and impaired glucose metabolism, which often precedes the development o
f overt diabetes, in patients with schizophrenia. Method: Twenty-one patien
ts with DSM-IV schizophrenia receiving neuroleptic medication were given or
al glucose tolerance tests involving serial glucose and insulin levels. The
se values were analyzed in relationship to abnormal involuntary movement ra
tings. Results: Patients with impaired glucose tolerance had higher mean ab
normal movement scores than those without glucose intolerance, but this dif
ference was not statistically significant. There was, however, an associati
on between the magnitude of the fasting insulin level and abnormal movement
s after the authors controlled for fasting glucose level. Additionally, the
fasting glucose level predicted abnormal movements after the authors contr
olled for age. Conclusions: Hyperinsulinemia and hyperglycemia associated w
ith insulin resistance may potentially contribute to the pathogenesis of ta
rdive dyskinesia. Findings from this small cross-sectional study suggest a
possible relationship that requires clarification through larger, longitudi
nal studies.